Terms ending in 2039
Every in-force patent on Genentech, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US D1,009,935 | Display Screen or Portion Thereof with Graphical User Interface In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 11,674,962 | Therapeutic and Diagnostic Methods for Cancer In force · High confidence | Foundation Medicine, Inc. | In force | High confidence | |
| US 11,473,151 | Diagnostic and Therapeutic Methods for Cancer In force · Low confidence | Genentech, Inc. | In force | Low confidence | |
| US 12,624,098 | Treatment of Age-Related Macular Degeneration and Diabetic Macular Edema by Administration of a Bispecific Antibody to VEGF and ANG-2 In force · Medium confidence | Hoffmann-La Roche Inc. | In force | Medium confidence | |
| US 11,485,975 | Oligonucleotides for Modulating TMEM106B Expression In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 12,297,270 | Bispecific Antigen-Binding Molecules and Methods of Use In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | |
| US 11,513,127 | Methods for Assaying T-Cell Dependent Bispecific Antibodies In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 11,834,461 | Bicyclic Ketone Compounds and Methods of Use Thereof In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 11,028,075 | Therapeutic Compounds and Methods of Use Thereof In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 11,076,984 | Method of Performing Subretinal Drainage and Agent Delivery In force · High confidence | Genentech, Inc. | In force | High confidence | |
| 35 more term ends in 2039 · Pro | |||||
10 of 45 patents shown. Soonest term end first, then patent number.
Pro members see all 45.
33 of these are in force and held by Genentech, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.